Ans Punt
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment
Papers in
-
- Carcinogens and Genotoxicity Assessment 25
-
- Effects and risks of endocrine disrupting chemicals 21
- Co-authors
- Ivonne M.C.M. Rietjens (44 shared papers)Peter J. van Bladeren (20 shared papers)Benoı̂t Schilter (13 shared papers)Thierry Delatour (9 shared papers)Bert Spenkelink (11 shared papers)Gabriele Scholz (12 shared papers)Jochem Louisse (9 shared papers)Marelle G. Boersma (10 shared papers)
- Journals
- Toxicological Sciences (9 papers)Chemical Research in Toxicology (8 papers)Archives of Toxicology (7 papers)Toxicology in Vitro (7 papers)Toxicology and Applied Pharmacology (6 papers)
- Partner nations
- NetherlandsSwitzerlandUnited Kingdom
In The Last Decade
Ans Punt
73 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 116
- Pharmacology 386
- Cancer Research 505
- Health, Toxicology and Mutagenesis 438
- Small Animals 189
- Food Science 334
Countries citing papers authored by Ans Punt
This map shows the geographic impact of Ans Punt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ans Punt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ans Punt more than expected).
Fields of papers citing papers by Ans Punt
This network shows the impact of papers produced by Ans Punt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ans Punt. The network helps show where Ans Punt may publish in the future.
Co-authors
The 25 scholars most cited alongside Ans Punt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 157 | |
| 2 | 2018 | 84 | |
| 3 | 2008 | 72 | |
| 4 | 2007 | 71 | |
| 5 | 2009 | 68 | |
| 6 | 2010 | 64 | |
| 7 | 2011 | 61 | |
| 8 | 2013 | 61 | |
| 9 | 2007 | 59 | |
| 10 | 2008 | 52 | |
| 11 | 2013 | 50 | |
| 12 | 2010 | 50 | |
| 13 | 2020 | 50 | |
| 14 | 2022 | 46 | |
| 15 | 2020 | 44 | |
| 16 | 2016 | 43 | |
| 17 | 2016 | 39 | |
| 18 | 2012 | 38 | |
| 19 | 2017 | 38 | |
| 20 | 2011 | 38 |
About Ans Punt
Ans Punt is a scholar working on Cancer Research, Health, Toxicology and Mutagenesis, Pharmacology, Molecular Biology and Small Animals, having authored 77 papers that have together received 2.0k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (25 papers), Effects and risks of endocrine disrupting chemicals (21 papers), Pharmacogenetics and Drug Metabolism (17 papers), Animal testing and alternatives (11 papers), Computational Drug Discovery Methods (10 papers), Genomics, phytochemicals, and oxidative stress (6 papers), Drug Transport and Resistance Mechanisms (6 papers) and Phytochemicals and Antioxidant Activities (5 papers). The work is most often cited by research in Pharmacology (386 citations), Cancer Research (505 citations), Health, Toxicology and Mutagenesis (438 citations), Small Animals (189 citations) and Food Science (334 citations). Ans Punt has collaborated with scholars based in Netherlands, Switzerland and United Kingdom. Frequent co-authors include Ivonne M.C.M. Rietjens, Peter J. van Bladeren, Benoı̂t Schilter, Thierry Delatour, Bert Spenkelink, Gabriele Scholz, Jochem Louisse, Marelle G. Boersma, A. Spenkelink and Alicia Paini. Their work appears in journals such as Toxicological Sciences, Chemical Research in Toxicology, Archives of Toxicology, Toxicology in Vitro and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.